With the rapid emergence of NA inhibitor-resistant strains after treatment with oseltamivir, the utility of NA inhibitors in the clinical treatment of influenza-infected patients is limited, so other drugs will be required to control H7N9 infection. The gene discussed is XK; the disease is influenza.